Maryll Toufanian is Senior Vice President, Regulatory Strategy and Policy, at Amneal Pharmaceuticals Inc., where she leads the company’s efforts to develop top-level regulatory strategies. She also leads Amneal’s government relations and public policy interface with state and federal policymakers. Prior to Amneal, Maryll held senior leadership roles at the FDA and served as Associate Chief Counsel for Drugs in FDA’s Office of Chief Counsel. Her career also includes time as private practice litigator focused on FDA regulatory matters and white-collar criminal defense. Maryll holds a J.D. from New York University School of Law, an M.A. in English Literature from the University of Texas at Austin, and a B.A. from the University of Michigan in Afro-American and African Studies and English.
Interactive Savings Map - Find out how much your state saved from generic and biosimilar medicines.